Osteocyte: the unrecognized side of bone tissue.
BACKGROUND
Osteocytes represent 95% of all bone cells. These cells are old osteoblasts that occupy the lacunar space and are surrounded by the bone matrix. They possess cytoplasmic dendrites that form a canalicular network for communication between osteocytes and the bone surface. They express some biomarkers (osteopontin, beta3 integrin, CD44, dentin matrix protein 1, sclerostin, phosphate-regulating gene with homologies to endopeptidases on the X chromosome, matrix extracellular phosphoglycoprotein, or E11/gp38) and have a mechano-sensing role that is dependent upon the frequency, intensity, and duration of strain.


CONCLUSIONS
The mechanical information transmitted into the cytoplasm also triggers a biological cascade, starting with NO and PGE(2) and followed by Wnt/beta catenin signaling. This information is transmitted to the bone surface through the canalicular network, particularly to the lining cells, and is able to trigger bone remodeling by directing the osteoblast activity and the osteoclastic resorption. Furthermore, the osteocyte death seems to play also an important role. The outcome of micro-cracks in the vicinity of osteocytes may interrupt the canalicular network and trigger cell apoptosis in the immediate surrounding environment. This apoptosis appears to transmit a message to the bone surface and activate remodeling. The osteocyte network also plays a recognized endocrine role, particularly concerning phosphate regulation and vitamin D metabolism. Both the suppression of estrogen following menopause and chronic use of systemic glucocorticoids induce osteocyte apoptosis. On the other hand, physical activity has a positive impact in the reduction of apoptosis. In addition, some osteocyte molecular elements like sclerostin, connexin 43, E11/gp38, and DKK1 are emerging as promising targets for the treatment of various osteo-articular pathologies.
Rochefort
G Y
GY
INSERM Research Unit 658, Centre Hospitalier Régional, 1 rue Porte Madeleine, 45 032 Orleans, France. gael.rochefort@gmail.com
Pallu
S
S
Benhamou
C L
CL
D000818:Animals; D017209:Apoptosis / Q000502:physiology; D015415:Biomarkers / Q000378:metabolism; D016723:Bone Remodeling / Q000502:physiology; D006801:Humans; D040542:Mechanotransduction, Cellular / Q000502:physiology; D009043:Motor Activity / Q000502:physiology; D010011:Osteocytes / Q000166:cytology / Q000378:metabolism / Q000502:physiology*; D010024:Osteoporosis / Q000188:drug therapy / Q000473:pathology; D010710:Phosphates / Q000378:metabolism; D051381:Rats; D014807:Vitamin D / Q000378:metabolism
D015415:Biomarkers; D010710:Phosphates; D014807:Vitamin D